Discontinuation report HOLKIRA PAK

Last updated on 2018-08-30 History
Report ID 31302
Drug Identification Number 02436027
Brand name HOLKIRA PAK
Common or Proper name HOLKIRA PAK 12.5/75/50/250MG TABS, 28DAY
Company Name ABBVIE CORPORATION
Active Ingredient(s) RITONAVIR Ombitasvir Dasabuvir Paritaprevir
Strength(s) 50MG 12.5MG 250MG 75MG
Dosage form(s) KIT TABLET
Route of administration ORAL
Packaging size 4 inner cartons x 7blisters
ATC code J05AX
ATC description DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2018-08-15
Actual discontinuation date 2018-08-15
Remaining supply date 2018-08-15
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Per AbbVie’s return policy, for your entire remaining inventory, we ask that you return product only at expiry.
Company comments This decision follows Health Canada’s recent approval of MAVIRET Tablets, AbbVie’s new pan-genotypic antiviral for the treatment of adults with chronic hepatitis C virus (HCV), which will replace HOLKIRA PAK, TECHNIVIE and MODERIBA on the Canadian market.
Health Canada comments
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-08-30 French Compare
v3 2018-08-30 English Compare
v2 2017-11-30 French Compare
v1 2017-11-30 English Compare